Impaired fibrinolysis and risk of thromboembolism
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 34 (3), 179-192
- https://doi.org/10.1016/0033-0620(91)90012-b
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemiaAmerican Heart Journal, 1990
- Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implicationsThe American Journal of Cardiology, 1989
- Lipoprotein a inhibits streptokinase-mediated activation of human plasminogenBiochemistry, 1989
- Impaired fibrinolysis in coronary artery diseaseAmerican Heart Journal, 1988
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Defective fibrinolysis in survivors of myocardial infarctionInternational Journal of Cardiology, 1984
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980